Friday, January 25, 2013

Epic Sciences wins Phase II SBIR contract to advance lung cancer assay - Pharmaceutical Business Review

Posted by at
Labels: , , , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)